Galderma Group N
Active …GALD.SW
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in …
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
41.04B CHF
Healthcare
Drug Manufacturers - Specialty & Generic
Switzerland
CHF
Common Stock
- Open
- —
- High
- —
- Low
- —
- Close / last
- —
- Volume
- —
- Prev close
- —
- Change
- —
- Change %
- —
- Session date
- —
- Quote time
- —
Wall Street Target
$194.37
PE Ratio (TTM)
59.46
Forward PE
45.66
Earnings per Share
$2.96
Dividend per Share
$0.44
Market Cap
41.04B
EBITDA
1.39B
Profit Margin
0.1457%
Dividend Yield
0.00%
Price / Sales (TTM)
6.930x
EPS Estimate (Current)
3.729
EPS Estimate (Next Year)
6.690
EV / Revenue
8.870x
EV / EBITDA
36.830x
Revenue Growth (YoY)
0.277%
Earnings Growth (YoY)
1.307%
Address
Zählerweg 10
Zug
6300
Switzerland
Phone
41 58 455 85 92Website
https://www.galderma.comEmployees
7676
Dr. Flemming Ornskov M.B.A., M.D., M.P.H.
CEO & Director
Born 1958
Mr. Adrian Murphy
Head of Global Operations
Born 1970
Mr. Christian Marcoux
Chief Communications Officer
Mr. Emil Ivanov
Head of Strategy, Investor Relations & ESG
Mr. Luigi Felice La Corte
Chief Financial Officer
Born 1969
Ms. Desislava Lazarova M.D.
Global Head of Customer Education & Training
Ms. Nakisa Serry J.D., MBA
General Counsel, Chief Compliance Officer & Interim CHRO
2026-07-23
Recent quarters & estimate trends
View full earnings (7)| Period | EPS Act. | EPS Est. | Surprise |
|---|---|---|---|
| Dec 2026 | — | — | — |
| Jun 2026 | — | 1.27 | — |
| Mar 2026 | — | 1.14 | — |
| Dec 2025 | 1.41 | — | — |
| Jun 2025 | 0.82 | 0.00 | — |
| Dec 2024 | 0.77 | 0.84 | -8.33% |
| Jun 2024 | 0.55 | 1.12 | -50.89% |
Estimate trends
Dec 2027
6.69 EPS est.
40.0% growth
Dec 2026
3.73 EPS est.
44.0% growth
Sep 2026
1.03 EPS est.
Jun 2026
1.27 EPS est.